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Abstract
Background: Recent studies suggest discrepancies between patients and providers around perceptions of
hemodialysis prognosis. Such data are lacking for continuous renal replacement therapy (CRRT). We aim to assess
patient and provider understanding of outcomes around CRRT.
Methods: From February 1 to August 31, 2013, a triad of (1) a patient on CRRT (or health care proxy [HCP]),
(2) physician and (3) primary nurse from the intensive care unit (ICU) team were surveyed. Univariate chi-square and
qualitative analysis techniques were used.
Results: Ninety-six total participants (32 survey triads) were completed. Ninety one percent of patients/HCPs
correctly identified that CRRT replaced the function of the kidneys. Six percent of patients/HCPs, 44 % of physicians,
and 44 % of nurses identified rates of survival to hospital discharge that were consistent with published literature.
Both physicians and nurses were more likely than patients/HCPs to assess survival consistently with published data
(p = 0.001). Patients/HCPs were more likely to overestimate survival rates than physicians and nurses (p < 0.001).
Thirty eight percent of patients/HCPs, 38 % of physicians, and 28 % of nurses identified rates of lifelong
dialysis-dependence among surviving patients that were consistent with published literature.
Conclusions: There is mismatch between patients, HCPs, and providers around prognosis of CRRT. Patients/HCPs
are more likely to overestimate chances of survival than physicians or nurses. Further intervention is needed to
improve this knowledge gap.
Keywords: Continuous renal replacement therapy, Intensive care unit, Kidney injury, Mismatch, Patient and provider
perspectives, Survey
Background
Continuous renal replacement therapy (CRRT) is often
employed in hemodynamically unstable patients in the
intensive care unit (ICU) with severe acute kidney injury
(AKI) and end stage renal disease (ESRD). [1, 2] In-
hospital mortality in this patient population is high, con-
sistently reported as over 50 %. [3–7] However, patients
with severe AKI that survive their hospital stay have an
excellent chance of recovering renal function; over 85 %
of these patients do not require indefinite renal replace-
ment therapy [3, 7, 8].
An accurate understanding of prognosis allows patients
and their health care proxies (HCPs) to make informed
decisions about goals of care. This understanding is crit-
ical to maintain good patient-provider relationships, and
may be associated with less psychosocial distress for pa-
tients and HCPs. [9–11] The majority of studies assessing
patient and provider expectations of illness are in onco-
logic disease. These data suggests that both groups over-
estimate likelihood of survival, with patients being more
optimistic than their physicians overall. [12–16] Similarly,
a recent survey study among nephrologists and patients
with ESRD showed that patients dramatically overestimate
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their probability of long-term survival and were more op-
timistic about their candidacy for renal transplantation
compared to their physicians [17].
Maintaining effective communication and making
shared treatment decisions pose many challenges in the
ICU setting. [18–23] The initiation of CRRT presents an
opportunity for patients/HCPs and ICU providers to dis-
cuss the logistics and implications of starting a new pro-
cedure and often leads to questions about expectations
of illness. Despite many attempts to identify potential
risk factors for poor outcomes in this patient population,
there is no widely accepted predictive model, and thus the
potential for communication mismatch exists. [3, 24, 25]
There are currently no studies in the literature that as-
sess the expectations of survival and renal recovery of
patients/HCPs, physicians, and critical care nurses
around patients receiving CRRT. We sought to assess
this potential mismatch of the prognostic assessment




Patients who were treated with CRRT in the medical or
cardiac ICUs at Massachusetts General Hospital (MGH)
between February and August 2013 were eligible for this
study. Patients were excluded if the primary medical
team did not feel that a survey study was appropriate
given the clinical context of the patient’s care (e.g., if pa-
tient’s care was limited to comfort measures). Surveys
were performed within the first 48 hrs of a patient start-
ing CRRT. Surveys were administered either verbally or
on paper depending on participant preference. If pa-
tients were unable to complete the survey (due to their
medical situation, e.g. intubation or sedation), their
HCPs were interviewed instead. No member of the re-
search team was directly involved in patient care for any
of the participants in this study. All surveys were per-
formed in English and all respondents self-reported flu-
ency in English.
MGH is a tertiary care hospital with 1008 total beds
and 126 ICU beds available for CRRT, 34 of which are in
the medical or cardiac ICU. CRRT is provided as con-
tinuous veno-venous hemofiltration using machines
from NxStage Medical (Lawrence, MA). All nurses who
perform CRRT have received specialized training and
have at least 18 months of critical care nursing experi-
ence at MGH. Decisions to initiate CRRT are made by
nephrologists in consultation with intensivists. CRRT is
performed in lieu of intermittent hemodialysis as per local
standard of care. Consent and education about CRRT was
performed as per standard of care by the consulting neph-
rology team prior to the initiation of CRRT. No formal
script or additional educational material around CRRT
was provided to those participating in this study by the
study team.
Survey Methodology
A member of the research team identified potential
index patient cases who were initiated on CRRT within
48 hrs by reviewing the ICU and nephrology consult
censuses. Each survey triad included (1) a patient on
CRRT (or their HCP), (2) an ICU physician from the pri-
mary care team, and (3) an ICU nurse currently employ-
ing CRRT for that patient. Patients/HCPs were given a
six question survey designed by the research team that
included one open ended question, two “true or false”
questions, and three multiple choice questions (Table 1).
Surveys assessed understanding of CRRT (questions 1–3),
expectations of survival and need for indefinite dialysis
(questions 4–5), and how well the care team explained
CRRT (question 6). In order to maximize comparability
within survey triads, multiple-choice questions were pre-
sented as four choices of percentage quartiles. Following
each patient/HCP survey, a member of the primary med-
ical ICU team and a primary nurse were independently
asked three analogous questions about general expecta-
tions of survival, likelihood of requiring indefinite dialysis,
and assessment of patient/HCP understanding of CRRT.
All participants were asked to give generalized answers
about patients on CRRT rather than the index case in
order to minimize bias. Providers who cared for more
than one patient enrolled in this study were only surveyed
once. Sufficient survey-naïve providers were available for
all index cases. Physicians surveyed were critical care at-
tendings, critical care or cardiology fellows, or internal
medicine trainees (post graduate year one through four)
and were selected based on survey-naïve status and clin-
ical availability. Medical records were reviewed for rele-
vant demographic and medical information about the
patient’s admission. Primary admitting diagnosis for each
patient was determined from the medical record discharge
summary.
Statistical Analysis
A prior study at MGH assessing all patients requiring
CRRT from 2008 to 2011 reported the probability of sur-
vival to hospital discharge between 25 % and 50 % and
the probability of requiring indefinite dialysis once dis-
charged at less than 25 %. [3] These results are sup-
ported by multiple prior studies. [4, 5, 7, 8, 26–34]
These responses were considered consistent with the lit-
erature when adjudicating responses.
Immersion crystallization and codebook analysis were
performed to identify important and recurring themes
for open-ended answers in question 1. [35, 36] Descrip-
tive analysis was performed for questions 2, 3, and 6.
Univariate Fisher’s exact analysis was performed for
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questions 4 and 5 to compare responses between pa-
tient/HCP, physician, and nurse subgroups. Univariate
rank sum and Fisher’s exact analyses were used for con-
tinuous and categorical variables, respectively, to analyze
for correlation between patient/provider demographic or
medical background information and correct answer
choices. STATA version 12.1 (StataCorp LP, College
Station, TX) was used for all statistical analysis.
A pre-determined interim analysis was performed after
20 survey triads were completed. After an additional 12
triads were completed without significant change to pre-
liminary results study recruitment was deemed complete.
Ethics Statement
Written informed consent was obtained from all study
participants. All responses and patient/provider informa-
tion were de-identified except to members of the re-
search team. The Partners Human Research Committee
for human subjects approved the study. All clinical in-
vestigation was conducted according to the principles
expressed in the Declaration of Helsinki.
Results
General Demographics
Ninety-six participants (32 survey triads) were inter-
viewed for this study. Twenty-three patients (72 %) were
hospitalized in a medical ICU and nine (28 %) were hos-
pitalized in a cardiac ICU. Twenty-five patients (78 %)
required CRRT for AKI and the remaining 7 patients
(22 %) had a diagnosis of ESRD. The most common pri-
mary diagnoses for ICU admission were sepsis/infection
(38 %), cardiogenic shock (16 %), and liver disease/
cirrhosis (16 %). From the patient/HCP subgroup, the
vast majority of responders were HCPs (88 %). Of the
four patients who responded themselves, three had a
diagnosis of ESRD. Eighteen of the 32 patients (56 %)
survived to hospital discharge. Of patients with AKI
who survived to discharge, twelve of the 15 patients
(80 %) recovered renal function (as defined by not re-
quiring any renal replacement therapy at discharge).
Physicians surveyed were attending physicians (22 %),
critical care or cardiology fellows (13 %), or medical res-
idents (66 %) between post graduate years one and four
of residency training (Table 2).
Closed-ended Survey Results
When asked true/false questions describing the proced-
ure, 91 % (n = 29/32) of patients/HCPs correctly identi-
fied the purpose of CRRT. Fifty three percent (n = 17/32)
of patients/HCPs incorrectly thought CRRT improved
the speed of renal recovery.
In multiple-choice format, 6 % of patients/HCPs
(n = 2/32), 44 % of physicians (n = 14/32), and 44 % of
nurses (n = 14/32) identified rates of survival to hospital
discharge consistently with published literature (25-49 %).
Both physicians (p = 0.001) and nurses (p = 0.001) were
more likely than patients/HCPs to assess survival consist-
ently with published data. Eighty-four percent (n = 27/32)
of patients/HCPs overestimated their likelihood of survival
by answering “≥75 %” (n = 18/32) or “50-74 %” (n = 9/32).
Thirty-four percent (n = 11/32) of physicians and 25 % (n
= 8/32) of nurses overestimated probability of survival
compared to the literature. Patients/HCPs were signifi-
cantly more likely to overestimate probability of survival
Table 1 Survey – Subjects were asked one open-ended question (question 1, patient/HCP only) and five multiple-choice questions
(questions 1–6)
Number Question Response
1 What is your understanding of this machine’s purpose? Open Ended
Patient/HCP only
2 CRRT is a procedure done on patients who have kidney failure




3 CRRT helps the kidneys heal faster True or False
Correct Answer: False
Patient/HCP only
4 How many patients who are treated with CRRT in the intensive care
unit will need to be on dialysis forever after leaving the hospital?
Multiple Choice
Choices: <25 %, 25-49 %, 50-75 %, ≥ 75 %
5 How many patients who are treated with CRRT in the intensive care
unit will survive and leave the hospital?
Multiple Choice
Choices: <25 %, 25-49 %, 50-75 %, ≥ 75 %
6 For Patients/HCP: How well did the doctors do in explaining why I
(or my family member) needs CRRT?
Multiple Choice
For MD and Nurse: How well do you feel the patient or HCP understands
why they need CRRT?
Choices: Completely, mostly, a little, not at all
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compared to physicians (p < 0.001) and nurses (p = <0.001;
Fig. 1). In a secondary analysis including a wider range of
survival rates as consistent with the literature (25-49 %
and 50-74 %), physicians and nurses remained more likely
to assess survival consistently with published data
compared to patients/HCPs (p = 0.005 and p = 0.01, re-
spectively). Within the patient/HCP subgroup, re-
sponses from patient respondents, children-HCPs and
spouse-HCPs were similar, as were responses for those
with AKI compared to ESRD.
In multiple-choice format, 38 % of patients/HCPs
(n = 12/32), 38 % of physicians (n = 12/32), and 28 % of
nurses (n = 9/32) identified the probability of requiring
lifelong dialysis if discharged consistently with published
literature (less than 25 %). There were no significant dif-
ferences between these three subgroups for this question
(p = 0.69; Fig. 1). No demographic factors correlated with
responses for renal recovery or survival in any of the three
subgroups. Within the physician subgroup, responses
from residents, fellows, and attending physicians were
similar. Within the patient/HCP subgroup, responses from
patient respondents, children-HCPs and spouse-HCPs
were similar, as were responses for those with AKI com-
pared to ESRD.
The majority of patients/HCPs answered that their
doctors “completely” explained the purpose of CRRT
(72 %, n = 23/32). In comparison, physicians and nurses
felt that patients/HCPs “mostly” understood the role of
this procedure (69 %, n = 22/32 for both subgroups),
while only one physician (3 %) and two nurses (6 %)
agreed that the patient/HCP had “complete” understand-
ing (Fig. 1).
Open-ended Survey Results
In question 1, patients/HCPs were asked to describe
the purpose of CRRT with an open-ended response
(Additional file 1: Table S1). Responses were varied
and covered several thematic areas. The most common
motif expressed was CRRT “cleaning” or “filtering” the
blood from toxins, which was present in 15 responses:
“…I know the blood is coming out, being cleansed,
and going back in - that’s why there are two lines.”
Five patients/HCPs identified CRRT as a replacement
for the native kidney. Three patients made comparisons
to intermittent HD (all three were initiated on CRRT for
acute kidney injury rather than for ESRD). Ten patients/
HCPs commented on the speed or duration of CRRT,
describing it as continuous, slower, or gentler than alter-
native forms of hemodialysis:
“My understanding was that it was used to clean the
toxins from the blood system. This is a slower
machine than all the hospitals have. His blood
pressure couldn’t take the stress of the other
machine.”
Four patients recognized CRRT was an extracorporeal
therapy and that blood was removed and then returned to
the body, with three additional patients acknowledging
Table 2 Demographics
Patient/HCP Demographics
Age, mean (range, standard deviation) 56 years (35–90 years, 14)
Patient (n = 4/32) 61 years (35–90 years, 14)
HCP (n = 28/32) 55 years (33–80 years, 14)
Male Gender 21 (66 %)
Reason for CRRT
AKI 25 (78 %)
ESRD 7 (22 %)
Race
White 23 (72 %)
Black 4 (13 %)
Non-black Hispanic 3 (9 %)
Other 2 (6 %)
Highest Level of Education
Did not complete high school 1 (3 %)
Completed high school 11 (34 %)
Partial college 6 (19 %)
Completed college 10 (31 %)
Post-graduate 4 (13 %)
Patient Location
Medical ICU 23 (72 %)
Cardiac ICU 9 (28 %)
Primary Diagnosis
Sepsis/Infection 12 (38 %)
Cardiogenic Shock 5 (16 %)
Liver disease/Cirrhosis 5 (16 %)
Pancreatitis 2 (6 %)
Hemorrhagic Shock 2 (6 %)
Other 6 (19 %)
Survived to Discharge (Patients) 18 (56 %)
Recovered Renal Function (of n = 15 AKI
patients who survived to discharge)
12 (80 %)
Level of Training of MDs
Attending 7 (22 %)
Fellow 4 (13 %)
Resident 21 (66 %)
Post graduate year (PGY) 1 3 (9 %)
PGY 2 9 (28 %)
PGY 3 or 4 9 (28 %)
All data for patient/HCP categories correspond to the survey responder unless
otherwise noted
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that this process would also remove fluid. Two patients
noted that they did not feel like they understood the
machine (both correctly answered the corresponding
true/false question about the machine’s purpose). Sev-
eral patients exhibited some level of misunderstanding
about the CRRT, most commonly stating that the ma-
chine “fixed” or “repaired” the kidneys, or giving the
machine credit for performing a function that it does
not do:
“To use the machine to help kick the kidneys to
produce urine…”
“The setup allows dialysis to occur in slow but direct
methods in which blood is pumped directly into her
to deliver medicine more quickly and directly.”
Discussion
Our study describes the single-center experience of mis-
match around patient/HCP and provider perceptions of
CRRT using a non-validated survey tool and descriptive
analysis techniques. Of note, most patients in this cohort
were too ill to participate in a survey, and therefore
88 % of responders from the patient/HCP group were
HCPs. While HCPs often must make decisions for
Question 4
How many patients who are treated with CRRT in the intensive care unit will 
need to be on dialysis forever after leaving the hospital? (consistent with 
prior literature: <25%)
Question 5
How many patients who are treated with CRRT in the intensive care unit will 

























Patient/HCP: How well did the doctors explain CRRT?























Completely Mostly A Little Not At All
Fig. 1 Perceptions of CRRT outcomes. Patients and/or health care proxies (HCP) were more likely to overestimate survival following continuous
renal replacement therapy (CRRT) and had a more positive view on provider/patient communication than physicians or nurses
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patients in the ICU, it should be noted that HCPs repre-
sented the majority of the patient/HCP subgroup, and
may not necessarily have the same views or understand-
ing as the patients themselves.
One of the most prominent findings in this study was
that all three subgroups – patients/HCPs, ICU physi-
cians, and nurses – provided answers that were incon-
sistent with published literature around survival and
likelihood of requiring long-term dialysis. Forty-four per-
cent of ICU physicians and nurses identified in-hospital
mortality rates consistently with the literature, as did just
6 % of patients/HCPs. All three subgroups were similarly
discrepant in assessing the likelihood of requiring long-
term dialysis compared to prior studies. While both
nurses and physicians were significantly more consistent
with published probabilities of survival than patients/
HCPs, these responses highlight a need for further edu-
cation for patients and providers alike. Our results are
consistent with prior literature examining attending and
resident physicians’ accuracy of prognosis. Survey stud-
ies around patients with acute congestive heart failure,
late stage cancer, and critical illness requiring ICU ad-
mission described similarly low rates of prognostic ac-
curacy. [13, 37–39] At our study site, consulting
nephrologists, rather than ICU physicians or nurses, ob-
tain informed consent for CRRT. This study did not as-
sess the degree of communication between consulting
nephrologists and the ICU care team and patients/
HCPs. The consent process is a natural time for pa-
tients/HCPs to ask questions about survival and poten-
tial long-term dialysis needs; this interaction may serve
as another potential target for investigation of percep-
tions of CRRT.
This study included only patients who were initiated
on CRRT, as opposed to intermittent hemodialysis.
While studies comparing outcomes between these two
populations have shown similar rates of survival and
long-term dialysis dependence, [40] the results of this
study are best generalized to the CRRT population. It
should also be noted that the 97 % of patient/HCPs
identified as having a high school education or greater.
Those with lower education levels might have even
worse prognostic estimates, though this conjecture re-
quires further study to evaluate in the CRRT population.
Compared to their physicians, our results show that
patients/HCPs overestimate the chance of survival,
which is consistent with prior literature comparing pa-
tient and provider views in the non-ICU setting. [12–17]
Our study is novel in that it also examines ICU nurses’
perceptions of patient outcomes. Despite the fact that
nurses have more direct contact with patients/HCPs
than physicians, [41, 42] we found no differences in the
responses of physicians and nurses. Nurses’ understand-
ing of illness may have a strong impact on patient/HCP
perceptions and expectations, and thus highlights an add-
itional opportunity for interventions to improve under-
standing of prognosis and communication in the ICU.
This concept requires further directed study to examine
the impact of nursing beliefs of illness on care of patients
with CRRT.
Perhaps the richest patient/HCP information came in
open-ended responses to question 1. Overall, responses
spanned several thematic areas important to the func-
tion of CRRT. With few exceptions, patients/HCPs were
generally accurate in describing some of the reasons
CRRT was employed. Answers were typically short, and
very few patients talked about CRRT as a life-supporting
measure. Answers typically focused on the mechanical
function of the device – commonly described as a filter,
a “slow” treatment, or as an extracorporeal device with
blood being removed then returned to the body. It is not
known if this pattern of responses was because the idea
of CRRT as life support (analogous to a ventilator, for
example) was not emphasized during the consent or pa-
tient education process, or because this was difficult of
patient/HCPs to acknowledge.
There is an interesting paradox that exists in the lit-
erature surrounding communication of advanced illness.
Even after candid conversations about advanced care
planning, patient/HCP understanding of prognosis and
surrogate decision-making preferences has been shown
to be low. [43, 44] However, recent data suggests that
many patients prefer to hear from their doctor if their
overall prognosis is poor, suggesting that providers
should feel both empowered and obligated to share as
much prognostic information as appropriate with pa-
tients and HCPs. [45, 46] These discussions can be chal-
lenging in the ICU setting, however, due to lack of
consistent prediction models, frequently evolving treat-
ment courses, variations in patient/HCP belief systems,
and the emotional stresses inherent to the ICU. [3, 18–25]
At this study site, there is no standardized patient edu-
cation process around CRRT, which may be a barrier to
improving discordance around CRRT. Augmenting dir-
ect clinician counseling with multimedia educational
tools, such as decision support videos, has been shown
to be successful in improving patient/HCP understand-
ing of illness and assisting in making decisions consist-
ent with patients’ value systems. [47] These tools have
been used in other patient populations with poor overall
prognosis, including counseling about cardiopulmonary
resuscitation in the ICU. [48–53] Our study highlights a
significant knowledge gap and communication mismatch
between patients/HCPs and ICU providers around CRRT,
suggesting that there may be a role for such a tool around
this intervention.
This study should be interpreted with the context of
its limitations. It was performed at a single site using a
Allegretti et al. BMC Nephrology  (2015) 16:105 Page 6 of 8
small sample, thus potentially limiting generalizability.
Since this study was not powered to pick up individual
predictors of accuracy, no patient or HCP demographic
factors correlated with answer choices. However, this
study was designed in large part to be a descriptive and
qualitative investigation of perceptions of illness across
parallel patient and provider groups. We feel that our
holistic message is more important than the power of
the individual data points. ICU physicians and nurses
were instructed to answer based on perceptions of over-
all survival and renal recovery rates (rather than for the
index patient case) in order to maximize objectivity and
comparability between groups. However, provider expec-
tations for each index patient may have had an influence
on answer choices due to temporal proximity to the sur-
vey, thus capturing some degree of bias. In line with this,
the survival rate in this sample was 59 %, which is higher
than the rates of less than 50 % that are routinely pub-
lished in the literature. This is likely explained by a selec-
tion bias, as sicker patients who had a higher mortality
were more likely to die (or transitioned to comfort care
measures) prior to being interviewed, thus artificially im-
proving survival in our sample. Still, this may have affected
responses in all three subgroups. Because no validated sur-
vey tool previously existed that could assess the questions
of this study, our research group had to create our own
short survey. Prior studies assessing patient understanding
of illness in hemodialysis and in the ICU have done so with
similar, non-validated survey tools, [17, 50] so we feel that
are results remain interpretable. Prior to the beginning of
the study, the survey tool was reviewed by two members
of each subgroup in order to ensure understandability.
These subjects were not included in the final analysis.
Conclusions
There is mismatch between patients/HCPs and ICU pro-
viders around prognosis of CRRT. Compared to physicians
and nurses, patients/HCPs are more likely to overestimate
the likelihood of survival on CRRT. Patients/HCPs may
overestimate their level of understanding of CRRT, and
may believe that CRRT improves the speed of renal recov-
ery. New strategies are needed in order to minimize this
discordance and improve the use of CRRT within the
framework of patient-centered treatment plans.
Additional file
Additional file 1: Patient/HCPs Responses to Question One: What is
your understanding of this machine’s purpose?
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